EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudieOpen Access · CC BY 4.0

Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium‐Competitive Acid Blockers

Kentaro Wakamatsu iD, Tsutomu Nishiyama iD, Kunio Yamada, Koya Yamada, Shohei Mitsumata, Tetsuharu Ikeda, Kouta Katsuki, Tomoki Takeyama, Ruriko Kiyotani, Izumi Fukui, Masayuki Kawasaki iD, Zenzo Nagasawa iD und 3 weitere

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/2610573 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BioMed Research International, online erschienen am 14.03.2026. Verfasst von Kentaro Wakamatsu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Hospital Organization Omuta National Hospital, Fukuoka, Japan, hosp.go.jp. Hauptthemen laut MEDLINE: Reagent Kits, Diagnostic, Helicobacter pylori, Helicobacter Infections, Proton Pump Inhibitors. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mizuho Medy Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Helicobacter pylori infection is associated with gastric cancer; therefore, therapies that eradicate H. pylori are crucial for its prevention. This study investigated the effects of clarithromycin (CAM)‐resistance gene mutations on the success rate of H. pylori eradication and the usefulness of the Smart Gene H. pylori G (Mizuho Medy Co. Ltd., Saga, Japan) molecular diagnostic kit for H. pylori infection, which detects CAM‐resistance mutations.

Methods

This study enrolled patients who underwent esophagogastroduodenoscopy, during which intragastric fluid was collected. The Smart Gene kit was used to diagnose H. pylori infection and CAM‐resistance mutations, and results were compared with those of the conventional urea breath test (UBT) and real‐time polymerase chain reaction (PCR) results.

Results

The study included 253 patients. H. pylori infection was confirmed by real‐time PCR in 23 (9.1%) patients, and 99 (39.1%) patients were receiving a proton pump inhibitor (PPI) or potassium‐competitive acid blocker (P‐CAB). The sensitivities and specificities of the Smart Gene test and UBT were 87.0% and 82.6%, as well as 99.6% and 93.0%, respectively. PPI/P‐CAB use did not affect the distribution of H. pylori DNA levels measured by real‐time PCR, but the UBT values were significantly lower in the medicated group than in the unmedicated group ( p < 0.05). Thirteen patients underwent treatment to eradicate H. pylori , with successful eradication in 11 (84.6%). The Smart Gene test identified three patients with CAM‐resistance mutations. One patient was successfully treated with a metronidazole‐based regimen, whereas CAM‐based eradication therapy failed in two patients.

Conclusions

The Smart Gene molecular diagnostic test using intragastric fluid was useful for patients requiring PPI/P‐CAB to manage gastrointestinal symptoms. It could also confirm an H. pylori infection and CAM‐resistance mutations within 1 h of testing. This diagnostic test may help reduce side effects and the emergence of resistant strains due to unnecessary eradication therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reagent Kits, DiagnosticHelicobacter pyloriHelicobacter InfectionsProton Pump InhibitorsEndoscopy, Digestive SystemMolecular Diagnostic TechniquesClarithromycinDrug Resistance, BacterialMutationDNA, BacterialBreath TestsHumansSensitivity and SpecificityMaleFemaleMiddle AgedAgedAged, 80 and overPolymerase Chain ReactionAnti-Bacterial Agents

Stichwörter der Autor:innen

Helicobacter pylori infectionSmart Geneclarithromycin resistancegene mutationsmolecular diagnostic kitpotassium-competitive acid blockerproton pump inhibitor

Substanzen

Reagent Kits, DiagnosticClarithromycinDNA, BacterialProton Pump InhibitorsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, National Hospital Organization Omuta National Hospital, Fukuoka, Japan, hosp.go.jp.
  • Department of Gastroenterology, Nishiyama Clinic, Fukuoka, Japan.
  • Department of Internal Medicine, Arao Clinic, Kumamoto, Japan.
  • Department of General Thoracic Surgery, Breast and Pediatric Surgery, Fukuoka University School of Medicine, Fukuoka, Japan, fukuoka-u.ac.jp.
  • Department of Medical Laboratory Science, Graduate School of Health and Welfare Sciences, International University of Health and Welfare Graduate School, Fukuoka, Japan.
  • Department of Respiratory Medicine, Fukuoka Sanno Hospital, Fukuoka, Japan.

ORCID-Profile: Kentaro Wakamatsu, Tsutomu Nishiyama, Masayuki Kawasaki, Zenzo Nagasawa, Nobuhiko Nagata, Satomi Asai, Takashi Hisabe

Förderung

  • Mizuho Medy Co. Ltd

Zitieren

APA

Wakamatsu, K., Nishiyama, T., Yamada, K., Yamada, K., Mitsumata, S., Ikeda, T., Katsuki, K., Takeyama, T., Kiyotani, R., Fukui, I., Kawasaki, M., Nagasawa, Z., Nagata, N., Asai, S., & Hisabe, T. (2026). Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium‐Competitive Acid Blockers. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/2610573

Vancouver

Wakamatsu K, Nishiyama T, Yamada K, Yamada K, Mitsumata S, Ikeda T, et al. Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium‐Competitive Acid Blockers. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/2610573

BibTeX
@article{Wakamatsu2026,
  author = {Wakamatsu, Kentaro and Nishiyama, Tsutomu and Yamada, Kunio and Yamada, Koya and Mitsumata, Shohei and Ikeda, Tetsuharu and Katsuki, Kouta and Takeyama, Tomoki and Kiyotani, Ruriko and Fukui, Izumi and Kawasaki, Masayuki and Nagasawa, Zenzo and Nagata, Nobuhiko and Asai, Satomi and Hisabe, Takashi},
  title = {Usefulness of Molecular Diagnostic Kits for Detecting Helicobacter pylori Infection in Patients Receiving Proton Pump Inhibitors and Potassium‐Competitive Acid Blockers},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/2610573}
}
Kostenlos starten →